Author(s):
Rana I. Ahmad, Zbeida B. Nassif, Zainab M. Ismail, Fahd F. Hasan
Email(s):
ranaad83@gmail.com
DOI:
10.5958/0974-360X.2020.00639.3
Address:
Rana I. Ahmad*, Zbeida B. Nassif, Zainab M. Ismail, Fahd F. Hasan
Department of Laboratory Medicine, Faculty of Medicine, Al Andalus University for Medical Sciences, Al Qadmus, Tartus, Syria.
*Corresponding Author
Published In:
Volume - 13,
Issue - 8,
Year - 2020
ABSTRACT:
Sickle cell anemia SCA is considered a major health problem in Syria. Due to this chronic hemolytic disease the gallstones is an important complication. The prevalence of gallstones has varied according to geographical areas worldwide, race and ethnicity. The main aim of this study is to determine the prevalence of gallstones among sickle cell patients at Obstetrics and Pediatrics Hospital in Lattakia, Syria. Out of 175 SCA patients; the prevalence of gallstones was 13.7%, the mean age of the patients with gallstones was 27±15.4 years, and male to female ratio was 1:1. High concentration of total bilirubin in the patients with gallstones compared with those without gallstones. There is no statistically significant relation between HbF levels and gallstones (P=0.663). Gallstones are important and common complication among sickle cell patients. The prevalence increases with age. Routine abdominal ultrasound examination should be applied to all sickle cell patients for early detection.
Cite this article:
Rana I. Ahmad, Zbeida B. Nassif, Zainab M. Ismail, Fahd F. Hasan. The Prevalence of gallstones in patients with Sickle cell anemia in Lattakia-Syria. Research J. Pharm. and Tech. 2020; 13(8):3615-3617. doi: 10.5958/0974-360X.2020.00639.3
Cite(Electronic):
Rana I. Ahmad, Zbeida B. Nassif, Zainab M. Ismail, Fahd F. Hasan. The Prevalence of gallstones in patients with Sickle cell anemia in Lattakia-Syria. Research J. Pharm. and Tech. 2020; 13(8):3615-3617. doi: 10.5958/0974-360X.2020.00639.3 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2020-13-8-12
REFERANCES:
1. Abdulla MM, Almoosa FJ, Almoosa RJ, Al Qamish J. A prospective study of the association between sickle cell disease and hepatobiliary effects in Bahrain. Int J Gen Med. 2017 Aug 4;10:221-226
2. Martins RA, Soares RS, De Vito FB, Barbosa VF, Saliva SH S, Moraes-Souza H, and Martins PRJ. Cholelithiasis and its complications in sickle cell disease in a university hospital. Rev bras hematolhemoter. 2017; 39(1):28–31.
3. Odunvbun ME, Adeyekun AA. Ultrasonic assessment of the prevalence of gall stones in sickle cell disease children seen at the University of Benin Teaching Hospital, Benin City, Nigeria. Niger J Paed 2014; 41(4):370–374.
4. Saied DA, El-Raziky M S, El-Ghamrawy M K AND Mahmoud MA. The pattern of hepatobiliary complications among Egyptian sickle cell disease children. Egyptian Pediatric Association Gazette 2017, 65, 54–59.
5. Gumiero APS, Bellomo-Brandão MA, Costa-Pinto EAL. Gallstones in children with sickle cell disease followed up at a Brazilian hematology center. Arq Gastroenterol, 2008; 45(4):313-318.
6. Tripathy D, Dash BP, Mohapatra BN, Kar BC. Cholelithiasis in sickle cell disease in India.J Assoc Physicians India. 1997 Apr; 45(4):287-9.
7. Abdullah U. Y. H., Jassim H. M. Baig A. A. Khorsheed R. M. Al-khayat A. M. H. Sulong A. F.Abed B. N. F. andYassin W. A. “Gallstones in patients with inherited hemolytic diseases”. International Journal of Pharmacy and Pharmaceutical Sciences. 2015May 7(7): 9-15.
8. Curro G, Meo A, Ippolito D, Pusiol A, and Cucinotta E. Asymptomatic Cholelithiasis in Children With Sickle Cell Disease Early or Delayed Cholecystectomy?. Ann Surg 2007; 245(1): 126–129.
9. Attalla BAI, Karrar ZA, Ibnouf G, Mohamed AO, Abdelwahab O, Nasir E M, El Seed. Outcome of cholelithiasis in Sudanese children with Sickle Cell Anaemia (SCA) after 13 years follow-up. African Health Sciences 2013; 13(1): 154 – 159.
10. Al-Salem AH, Jaber A, Abu-Srair H, Al-Jama A, Al-Jishi N. Cholelithiasis in Saudi patients with sickle cell anemia. Ann Saudi Med. 1992 Jul; 12(4):387-90.
11. Karayalcin G, Hassani N, Abrams M, Lanzkowsky PH. Cholelithiasis in children with sickle cell disease. Am J Dis Child 1984; 133:306-7.
12. Walker TM, Hambleton IR, Serjeant GR. Gallstones in sickle cell disease: observations from the Jamaican Cohort Study. J Pediatr. 2000 Jan; 136 (1):80-5.
13. Nzeh DA, Adedoyin MA. Sonographic pattern of gallbladder disease in children with sickle cell anemia. Pediatr Radiol. 1989; 19 (5):290–292.
14. Billa R F, Biwole M S, Juimo A G, Bejanga B I, Blackett K. Gall stone disease in African patients with sickle cell anaemia: a preliminary report from Yaounde, Cameroon. Gut. 1991 May; 32(5): 539–541.
15. Bond L R, Hatty S R, Horn M E C, Dick M, Meire H B, Bellingham A J. Gall stones in sickle cell disease in the United. Kingdom.Br Med J (Clin Res Ed). 1987 Jul 25; 295(6592): 234–236.
16. Qhalib HA, and Zain GH. Hepatobiliary Complications of Sickle Cell Disease among Children Admitted to Al Wahda Teaching Hospital, Aden, Yemen. SQU Medical Journal.2014November 14(4): 556-560.
17. Darko R, Rodrigues OP, Oliver Commey JO, Kotei CN. Gallstones in Ghanaian children with sickle cell disease. West Afr J. Med 2000; 24 (4) 295-8.
18. Webb DKH, Darby JS, Dunn DT, Terry SI, and Sergeant GR: Gallstone in Jamaican children with homozygous sickle cell diseases. Arch Dis Child 1989; 64:693-6.